Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
7.50
-0.52 (-6.48%)
Mar 31, 2025, 1:41 PM EDT - Market open
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $438.85 million as of March 31, 2025. Its market cap has decreased by -39.59% in one year.
Market Cap
438.85M
Enterprise Value
31.20M
1-Year Change
-39.59%
Ranking
Category
Stock Price
$7.50
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $438.85M, a decrease of -47.09%. That is a compound annual growth rate of -14.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 469.27M | -33.83% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |